Skip to main content
SpringerLink
Log in
Book cover

Modern Infectious Disease Epidemiology pp 333–356Cite as

Blood Borne and Sexual Transmission: Hepatitis B and C

  • Chapter
  • First Online:

  • 7607 Accesses

Part of the book series: Statistics for Biology and Health ((SBH))

Abstract

Although the routes of transmission and infectivity differ, the three blood borne infections with most impact on public health are caused by viruses that can cause chronic asymptomatic infections. Human immunodeficiency virus (HIV) is discussed in Chapter 3.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Alter MJ (2002) Prevention of spread of hepatitis C. Hepatology; 36(5):593–598

    Google Scholar 

  • Alter MJ (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol; 13(17):2436–2441

    Google Scholar 

  • Anzola M, Burgos JJ (2003) Hepatocellular carcinoma: molecular interactions between hepatitis C virus and p53 in hepatocarcinogenesis. Expert Rev Mol Med; 5(28):1–16

    Article  Google Scholar 

  • Aweis D, Cooper CD, Brabin B, Beeching N (2001) Serological evidence for Hepatitis B infection in the Somali population of Liverpool. Arch Dis Child; 84 (suppl I):A62

    Google Scholar 

  • Bassett SE, Guerra B, Brasky K, Miskovsky E, Houghton M, Klimpel GR et al. (2001) Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology; 33(6):1479–1487

    Article  Google Scholar 

  • Beasley RP, Trepo C, Stevens CE, Szmuness W (1977) The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol; 105(2):94–98

    Google Scholar 

  • Blackard JT, Sherman KE (2007) Hepatitis C virus coinfection and superinfection. J Infect Dis; 195(4):519–524

    Article  Google Scholar 

  • Bonanni P, Pesavento G, Bechini A, Tiscione E, Mannelli F, Benucci C et al. (2003) Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine; 21(7–8):685–691

    Article  Google Scholar 

  • Boot HJ, Cremer J, Koedijk F, Ballegooijen M, Op de Coul ELM (2008) Improved tracing of hepatitis B virus transmission chains by phylogenetic analysis based on C region sequences. J Med Virol; 80:233–241

    Google Scholar 

  • Bowker SL, Smith LJ, Rosychuk RJ, Preiksaitis JK (2004) A review of general hepatitis C virus lookbacks in Canada. Vox Sang; 86(1):21–27

    Article  Google Scholar 

  • Busch MP (2001) Closing the window on viral transmission in blood transfusion. In: Stramer SL, ed. Blood safety in the new milennium. American Association of Blood Banks:Betehsda, MD; 33–54

    Google Scholar 

  • Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F et al. (2008)Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b. Gastroenterology; 135(2):459–467

    Google Scholar 

  • Chamie G, Bonacini M, Bangsberg DR, Stapleton JT, Hall C, Overton ET et al. (2007) Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis; 44(4):577–583

    Article  Google Scholar 

  • Coleman PJ, McQuillan GM, Moyer LA, Lambert SB, Margolis HS (1998) Incidence of hepatitis B virus infection in the United States, 1976–1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis; 178(4):954–959

    Article  Google Scholar 

  • Courouce AM, Drouet J, Muller JY (1976) Australia antigen subtypes identification. Results. Bibl Haematol; 42:89–127

    Google Scholar 

  • Danta M, Brown D, Bhagani S, Pybus OG, Sabin CA, Nelson M et al. (2007) Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS; 21(8):983–991

    Article  Google Scholar 

  • Davis LG, Weber DJ, Lemon SM (1989) Horizontal transmission of hepatitis B virus. Lancet; 1(8643):889–893

    Article  Google Scholar 

  • de Oliveira T, Pybus OG, Rambaut A, Salemi M, Cassol S, Ciccozzi M et al. (2006) Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak. Nature; 444(7121):836–837

    Article  Google Scholar 

  • Deuffic-Burban S, Mohamed MK, Larouze B, Carrat F, Valleron AJ (2006) Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol; 44(3):455–461

    Article  Google Scholar 

  • Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB (2007) Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepat; 14(2):107–115

    Article  Google Scholar 

  • Dove L, Phung Y, Bzowej N, Kim M, Monto A, Wright TL (2005) Viral evolution of hepatitis C in injection drug users. J Viral Hepat; 12(6):574–583

    Article  Google Scholar 

  • Echevarria JM, Avellon A (2006) Hepatitis B virus genetic diversity. J Med Virol; 78 (Suppl 1):S36–S42

    Article  Google Scholar 

  • Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC (1993) The influence of age on the development of the hepatitis B carrier state. Proc R Soc Lond B Biol Sci; 253(1337):197–201

    Article  Google Scholar 

  • European Association for the Study of the Liver (2009) EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol; 50:227–242

    Article  Google Scholar 

  • Fisker N, Carlsen NL, Kolmos HJ, Tonning-Sorensen L, Host A, Christensen PB (2006) Identifying a hepatitis B outbreak by molecular surveillance: a case study. BMJ; 332(7537):343–345

    Article  Google Scholar 

  • Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA et al. (2004) Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int; 65(6):2335–2342

    Google Scholar 

  • Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS et al. (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet; 355(9207):887–891

    Article  Google Scholar 

  • Gale M, Jr., Foy EM (2005) Evasion of intracellular host defence by hepatitis C virus. Nature; 436(7053):939–945

    Article  Google Scholar 

  • Gerberding JL (1995) Management of occupational exposures to blood-borne viruses. N Engl J Med; 332(7):444–451

    Article  Google Scholar 

  • Giraudon I, Ruf M, Maguire H, Charlett A, Ncube F, Turner J et al. (2007).Increase in newly acquired hepatitis C in HIV positive men who have sex with men across London and Brighton, 2002–2006. Is this an outbreak? Sex Transm Infect 84(2):111–115

    Google Scholar 

  • Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS (2005) A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol; 34(6):1329–1339

    Article  Google Scholar 

  • Hahné S, Ramsay M, Balogun K, Edmunds WJ, Mortimer P (2004) Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995–2000: Implications for immunisation policy. J Clin Virol; 29:211–220

    Article  Google Scholar 

  • Hahné S, Ramsay M, Soldan K, Balogun K, Mortimer P (2003) Hepatitis B incidence among South Asian children in England and Wales: implications for immunisation policy. Arch Dis Child; 88:1082–1083

    Article  Google Scholar 

  • Hauri AM, Armstrong GL, Hutin YJ (2004) The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS; 15(1):7–16

    Article  Google Scholar 

  • Herring BL, Page-Shafer K, Tobler LH, Delwart EL (2004) Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis; 190(8):1396–1403

    Article  Google Scholar 

  • Hoofnagle JH (2002) Course and outcome of hepatitis C. Hepatology; 36(5):521–529

    Google Scholar 

  • Hurie MB, Mast EE, Davis JP (1992) Horizontal transmission of hepatitis B virus infection to United States- born children of Hmong refugees. Pediatrics; 89(2):269–273

    Google Scholar 

  • Hutton DW, Tan D, So SK, Brandeau ML (2007) Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Ann Intern Med; 147(7):460–469

    Google Scholar 

  • Kalinina O, Norder H, Magnius LO (2004) Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation. J Gen Virol; 85(7):1853–1857

    Article  Google Scholar 

  • Kingsley LA, Rinaldo CR Jr., Lyter DW, Valdiserri RO, Belle SH, Ho M (1990) Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men. JAMA; 264(2):230–234

    Article  Google Scholar 

  • Lanotte P, Dubois F, Le PS, Guerois C, Fimbel B, Bacq Y et al. (1998) The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs. J Infect Dis; 178(2):556–559

    Google Scholar 

  • Lavanchy D (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat; 11(2):97–107

    Article  Google Scholar 

  • Lok AS (2002) Chronic hepatitis B. N Engl J Med; 346(22):1682–1683

    Article  Google Scholar 

  • Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology; 45(2):507–539

    Article  Google Scholar 

  • Madhava V, Burgess C, Drucker E (2002) Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis; 2(5):293–302

    Article  Google Scholar 

  • Mallette C, Flynn MA, Promrat K (2007) Outcome of screening for hepatitis C virus infection based on risk factors. Am J Gastroenterol 103(1):131–137

    Google Scholar 

  • Memon MI, Memon MA (2002) Hepatitis C: an epidemiological review. J Viral Hepat; 9(2):84–100

    Article  Google Scholar 

  • Medley GF, Lindop NA, Edmunds WJ, Nokes DJ (2001) Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control. Nat Med; 7(5):619–624

    Article  Google Scholar 

  • Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S et al. (2002) Protection against persistence of hepatitis C. Lancet; 359(9316):1478–1483

    Article  Google Scholar 

  • Micallef JM, Kaldor JM, Dore GJ (2006) Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat; 13(1):34–41

    Article  Google Scholar 

  • Micallef JM, Macdonald V, Jauncey M, Amin J, Rawlinson W, van Beek I et al. (2007) High incidence of hepatitis C virus reinfection within a cohort of injecting drug users. J Viral Hepat; 14(6):413–418

    Article  Google Scholar 

  • Murphy DG, Willems B, Deschenes M, Hilzenrat N, Mousseau R, Sabbah S (2007) Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences. J Clin Microbiol; 45(4):1102–1112

    Article  Google Scholar 

  • National Institutes of Health Consensus Development Conference Statement (2002) Management of hepatitis C: 2002-June 10–12, 2002. Hepatology; 36(5 Suppl 1):S3–20

    Google Scholar 

  • Ndiaye SM, Hopkins DP, Shefer AM, Hinman AR, Briss PA, Rodewald L et al. (2005) Interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high-risk adults: a systematic review. Am J Prev Med; 28(5 Suppl):248–279

    Article  Google Scholar 

  • Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL et al. (2007) Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology; 132(4):1287–1293

    Article  Google Scholar 

  • Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK et al. (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology; 47(6):289–309

    Article  Google Scholar 

  • Novick DM, Kreek MJ (2008) Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients. Addiction; 103(6):905–918

    Article  Google Scholar 

  • Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M (1991) Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med; 324(24):1699–1704

    Article  Google Scholar 

  • Patel K, Muir AJ, McHutchison JG (2006) Diagnosis and treatment of chronic hepatitis C infection. BMJ; 332(7548):1013–1017

    Article  Google Scholar 

  • Posthouwer D, Plug I, van der Bom JG, Fischer K, Rosendaal FR, Mauser-Bunschoten EP (2005) Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment. Haemophilia; 11(3):270–275

    Article  Google Scholar 

  • Pybus OG, Drummond AJ, Nakano T, Robertson BH, Rambaut A (2003) The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol Biol Evol; 20(3):381–387

    Article  Google Scholar 

  • Salisbury D, Ramsay M, Noakes Keds. (2006) Immunisation against infectious disease. HMSO: London

    Google Scholar 

  • Scheinmann R, Hagan H, Lelutiu-Weinberger C, Stern R, Des Jaklais D, Flom PL et al. (2007) Non-injection drug use and Hepatitis C Virus: a systematic review. Drug and Alcohol Dependence; 89(1):1–12

    Article  Google Scholar 

  • Seeff LB (2002) Natural history of chronic hepatitis C. Hepatology; 36(5):S35–S36

    Google Scholar 

  • Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev; 28:112–125

    Article  Google Scholar 

  • Simmonds P (2001) The origin and evolution of hepatitis viruses in humans. J Gen Virol; 82(Pt 4):693–712

    Google Scholar 

  • Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S et al. (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology; 42(4):962–973

    Article  Google Scholar 

  • Sutton AJ, Gay NJ, Edmunds WJ (2006b) Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales. Vaccine; 24(13):2377–2386

    Article  Google Scholar 

  • Sutton AJ, Gay NJ, Edmunds WJ, Hope VD, Gill ON, Hickman M (2006a) Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. BMC Infect Dis; 6:93

    Article  Google Scholar 

  • Sweeting MJ, de Angelis D, Neal KR, Ramsay ME, Irving WL, Wright M et al. (2006) Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment. J Clin Epidemiol; 59(2):144–152

    Article  Google Scholar 

  • Sypsa V, Hadjipaschali E, Hatzakis A (2001) Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees. Eur J Epidemiol; 17(8):721–728

    Article  Google Scholar 

  • Sypsa V, Touloumi G, Papatheodoridis GV, Tassopoulos NC, Ketikoglou I, Vafiadis I et al. (2005) Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments. J Viral Hepat; 12(5):543–550

    Article  Google Scholar 

  • Takeda A, Jones J, Shepherd J, Davidson P, Price A (2007) A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon-alpha-2a for the treatment of chronic hepatitis B. J Viral Hepat; 14(2):75–88

    Article  Google Scholar 

  • Takkenberg B, de Bruijne J, Weegink C, Jansen P, Reesink H (2008) Novel therapies in hepatitis B and C. Curr Gastroenterol Rep; 10(1):81–90

    Article  Google Scholar 

  • Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T et al. (2002) Inaugural Article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA; 99(24):15584–15589

    Article  Google Scholar 

  • The Global Burden Of Hepatitis C Working Group (2004) Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol; 44(1):20–29

    Article  Google Scholar 

  • Thio CL, Seaberg EC, Skolasky R, Jr., Phair J, Visscher B, Munoz A et al. (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet; 360(9349):1921–1926

    Article  Google Scholar 

  • Thompson ND, Perz JF, Moorman AC, Holmberg SD (2009) Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998–2008. Ann Intern Med; 150(1):33–39

    Google Scholar 

  • Tillmann HL, Hadem J, Leifeld L, Zachou K, Canbay A, Eisenbach C et al. (2006) Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat; 13(4):256–263

    Article  Google Scholar 

  • van de Laar TJ, Pybus OG, Bruisten SM, Brown D, Nelson M, Bhagani S et al. (2009) Evidence of a large, international HCV transmission network in HIV-positive men who have sex with men. Gastroenterology 136(5):1609–1617

    Google Scholar 

  • Vandelli C, Renzo F, Romano L, Tisminetzky S, De Palma M, Stroffolini T et al. (2004) Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol; 99(5):855–859

    Article  Google Scholar 

  • van den Berg C, Smit C, van Brussel G, Coutinho R, Prins M (2007) Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction; 102(9):1454–1462

    Article  Google Scholar 

  • van Houdt R, Bruisten SM, Koedijk FD, Dukers NH, op de Coul EL, Mostert MC et al. (2007) Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: nationwide survey. J Med Virol; 79(7):895–901

    Google Scholar 

  • van Houdt R, Koedijk FDH, Bruisten SM, op de Coul EL, Heijnen MLA, Waldhober Q, et al. (2009) Hepatitis B vaccination targeted toward behavioral-risk groups in the Netherlands: does it work? Vaccine 27(27):3530–3535

    Google Scholar 

  • van Steenbergen JE, Niesters HGM, Op de Coul ELM, van Doornum GJJ, Osterhaus ADME, Leentvaar-Kuijpers A et al. (2002) Molecular epidemiology of Hepatitis B Virus in Amsterdam 1992–1997. J Med Virol; 66:159–165

    Google Scholar 

  • Vickerman P, Hickman M, Judd A (2007) Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study. Int J Epidemiol; 36(2):396–405

    Article  Google Scholar 

  • Weigand K, Stremmel W, Encke J (2007) Treatment of hepatitis C virus infection. World J Gastroenterol; 13(13):1897–1905

    Google Scholar 

  • Williams JR, Nokes DJ, Medley GF, Anderson RM (1996). The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes. Epidemiol Infect; 116(1):71–89

    Google Scholar 

  • Wright NM, Tompkins CN (2006) A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users. Harm Reduct J; 3:27

    Article  Google Scholar 

  • Xiridou M, Wallinga J, Dukers-Muijers N, Coutinho R (2008) Hepatitis B vaccination and changes in sexual risk behaviour among men who have sex with men in Amsterdam. Epidemiol Infect; 137(4):504–512

    Google Scholar 

  • Yeung LT, King SM, Roberts EA (2001) Mother-to-infant transmission of hepatitis C virus. Hepatology; 34(2):223–229

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cluster Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, Netherlands

    Freke Zuure, Thijs van de Laar & Maria Prins

  2. Center for Infectious Disease Control, RIVM, Bilthoven, Netherlands

    Susan Hahné

  3. Center for Infectious Disease Control, RIVM, Bilthoven, The Netherlands

    Jim van Steenbergen

Authors
  1. Freke Zuure
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan Hahné
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thijs van de Laar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Prins
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jim van Steenbergen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Freke Zuure .

Editor information

Editors and Affiliations

  1. Fak. Gesundheitswissenschaften, Universität Bielefeld, Universitätsstr. 25, Bielefeld, 33615, Germany

    Alexander Krämer

  2. University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, Netherlands

    Mirjam Kretzschmar

  3. Manglieu, 63270, France

    Klaus Krickeberg

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Zuure, F., Hahné, S., van de Laar, T., Prins, M., van Steenbergen, J. (2009). Blood Borne and Sexual Transmission: Hepatitis B and C. In: Krämer, A., Kretzschmar, M., Krickeberg, K. (eds) Modern Infectious Disease Epidemiology. Statistics for Biology and Health. Springer, New York, NY. https://doi.org/10.1007/978-0-387-93835-6_19

Download citation

Publish with us

Policies and ethics

Search

Navigation